Open Access

Does OAC reversal matter to your cardiac patients?

Topic: Clinical
Sponsored by Boehringer Ingelheim

Presentation

About the speaker

Professor Charles Pollack

VERO Biotech, Atlanta (United States of America)
4 presentations
0 follower

4 more presentations in this session

The heart of the matter: selecting the right OAC for stroke prevention in patients with AF.

Speaker: Doctor J. Halperin (New York, US)

Thumbnail

Latest developments for uninterrupted anticoagulation in atrial fibrillation ablation.

Speaker: Professor S. Willems (Hamburg, DE)

Thumbnail

Latest developments for dual vs triple antithrombotic therapy post-PCI.

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Discussion and close: anticoagulation in atrial fibrillation and beyond.

Speaker: Doctor J. Halperin (New York, US) Professor G. Lip (Liverpool, GB)

Thumbnail

Access the full session

Dabigatran use in diverse cardiology settings

Speakers: Professor C. Pollack, Doctor J. Halperin, Professor S. Willems, Professor G. Lip, Doctor J. Halperin...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Related content

ESC Premium Access

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

28 August 2021

This platform is supported by

logo Novo Nordisk